查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1383636

马保健市场 - 全球产业规模、份额、趋势、机会和预测，2018-2028 年按产品、适应症、活动、配销通路、地区、竞争预测和机会细分，2018-2028 年

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年全球马保健市场价值为 25.2 亿美元，预计在预测期内将出现令人印象深刻的增长，到 2028 年CAGR为5.94%。全球马保健市场是指致力于马匹健康和福祉的行业。马匹。它涵盖广泛的产品和服务，旨在维持和改善马匹的健康，无论是出于娱乐还是竞技目的。

主要市场驱动因素

马术运动和活动的参与度不断提高

市场概况
预测期 2024-2028
2022 年市场规模 25.2亿美元
2028 年市场规模 35.5亿美元
2023-2028 年CAGR 5.94%
成长最快的细分市场 兽医医院和诊所
最大的市场 北美洲

马术运动和活动有着悠久的历史，可以跨越几个世纪，从古希腊的历史性比赛到现代的奥林匹克盛装舞步赛场。曾经的小众兴趣现已发展成为一种全球现象，数以百万计的马术爱好者参与了各种马术项目。马术参与度的激增不仅塑造了体育格局，也推动了全球马匹医疗保健市场的成长。随着马术运动的兴起，越来越多的人开始投资养马。无论是竞技性骑马、休閒或陪伴，马匹拥有量的增加都对马匹医疗服务和产品产生了巨大的需求。马主认识到需要确保马匹伴侣的健康和福祉，并正在推动马匹医疗保健市场的成长。不断壮大的马术社群提高了人们对马匹健康和预防措施重要性的认识。马主、骑手和驯马师都知道，定期的兽医检查、疫苗接种和适当的营养对于保持马匹处于最佳状态至关重要。这种意识的提高推动了对马匹医疗保健解决方案的需求，并鼓励采取积极主动的马匹护理方法。从地方比赛到国际锦标赛的马术赛事吸引了大量观众和参与者。马术障碍赛、盛装舞步和牛仔竞技等赛事拥有热情的追随者，吸引来自世界各地的骑手和爱好者。这些事件在马术生态系统中产生了大量的经济活动，导致对马保健产品和服务的投资增加。随着马术运动的发展，对专业训练和教练的需求也随之而来。驯马师和教练强调对马匹进行适当护理和保健的重要性。这种教育不仅确保了动物的福祉，也推动了马保健产品和服务的使用。马术运动的发展刺激了马匹医疗保健技术的进步。最先进的诊断工具、数位影像和先进的治疗方案越来越容易获得，从而提高了马匹的护理品质。这些创新不仅有利于动物的健康，也吸引了马主为他们的马伙伴寻求最佳的医疗保健选择。马术世界极为多元化，涵盖从赛马到牛仔竞技、三项赛和治疗性马术等广泛的学科。这种多样性促进了广泛的马匹医疗保健需求，从管理赛马损伤到确保治疗马的健康。马医疗保健市场正在不断发展，以满足每个学科的具体要求，进一步推动其成长。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球马保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图
    • 按产品分类
    • 按指示
    • 按活动
    • 按配销通路
    • 按地区

第 6 章：北美马医疗保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲马保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太马医疗保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章：南美洲马医疗保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲马医疗保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（疫苗、药品、药用饲料添加剂、诊断、软体和服务、其他）
    • 依适应症（肌肉骨骼疾病、寄生虫控制、内科、马疱疹病毒、马脑​​脊髓炎、马流感、西尼罗河病毒、破伤风、其他）
    • 按活动（运动/赛车、休閒、其他）
    • 按配销通路（兽医院和诊所、电子商务、其他）
    • 按国家/地区
  • MEA：国家分析
    • 南非马匹保健
    • 沙乌地阿拉伯马匹保健
    • 阿联酋马匹保健
    • 科威特马匹保健

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Zoetis Inc.
    • Boehringer Ingelheim GmbH
    • Merck & Co., Inc.
    • Hallmarq Veterinary Imaging Ltd
    • Esaote SpA
    • Vetoquinol SA
    • IDEXX Laboratories, Inc.
    • Dechra Pharmaceuticals PLC

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 17486

Global Equine Healthcare Market has valued at USD 2.52 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.94% through 2028. The global equine healthcare market refers to the industry dedicated to the health and well-being of horses. It encompasses a wide range of products and services designed to maintain and improve the health of horses, both for recreational and competitive purposes.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.52 Billion
Market Size 2028USD 3.55 Billion
CAGR 2023-20285.94%
Fastest Growing SegmentVeterinary Hospitals & Clinics
Largest MarketNorth America

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market. As equestrian sports gain prominence, more people are investing in horse ownership. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market. The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care. Equestrian events, from local competitions to international championships, draw large audiences and participants. Events like show jumping, dressage, and rodeo have passionate followings, attracting riders and enthusiasts from around the world. These events generate substantial economic activity within the equestrian ecosystem, leading to increased investment in equine healthcare products and services. With the growth of equestrian sports comes a demand for specialized training and coaching. Trainers and coaches emphasize the importance of proper care and healthcare protocols for horses. This education not only ensures the well-being of the animals but also drives the use of equine healthcare products and services. The growth in equestrian sports has spurred technological advancements in equine healthcare. State-of-the-art diagnostic tools, digital imaging, and advanced treatment options are increasingly accessible, improving the quality of care for horses. These innovations are not only beneficial to the health of the animals but also attract horse owners seeking the best healthcare options for their equine companions. The equestrian world is incredibly diverse, encompassing a wide range of disciplines from racing to rodeo, eventing, and therapeutic riding. This diversity fosters a broad spectrum of equine healthcare needs, from managing injuries in racehorses to ensuring the well-being of therapy horses. The equine healthcare market is evolving to cater to the specific requirements of each discipline, further driving its growth.

Growing Awareness of Preventive Healthcare

In the world of equine health, prevention is not only better than cure; it's also an increasingly popular approach among horse owners and enthusiasts. As awareness of the importance of preventive healthcare continues to grow, it is emerging as a potent driver behind the expansion of the global equine healthcare market. The modern horse owner understands that good health is paramount to their horse's well-being and performance. This mindset shift from merely treating illnesses to actively preventing them has led to a surge in demand for preventive healthcare products and services. As equine healthcare takes center stage, the market responds with a wider array of preventative options. Preventive healthcare often begins with regular check-ups and vaccinations. Horse owners now appreciate the importance of scheduling routine veterinary visits to catch potential health issues before they escalate. This proactive approach ensures that horses remain in the best possible condition and minimizes the need for costly treatments down the road. Proper nutrition plays a critical role in preventing health problems in horses. Owners are increasingly seeking guidance on nutrition tailored to their horse's specific needs. This has led to a growing market for equine supplements, including vitamins, minerals, and joint support products, to keep horses in optimal condition. Equine parasites can pose significant health risks if left unchecked. Horse owners are now well-informed about the importance of parasite control through regular deworming and fecal testing. As a result, the demand for effective parasite control products has surged. Dental health is an integral aspect of preventive care. Regular dental check-ups and proper dental care can prevent issues like malocclusions and tooth decay. Dentists specializing in equine dental care are in high demand, contributing to the growth of the equine healthcare market. Maintaining a horse's physical fitness is another preventive strategy. Many horse owners now invest in exercise and conditioning programs that not only improve performance but also help prevent injuries and health issues. The internet and access to information have empowered horse owners to become more educated about equine health. Online resources, forums, and educational materials have made it easier for horse owners to stay informed and make informed decisions about their horse's healthcare.

Technological Advancements in Diagnostics and Treatment

In the realm of equine health, innovation knows no bounds. With the rapid evolution of diagnostic tools and treatment technologies, the global equine healthcare market is galloping ahead like never before. This surge in technological advancements has not only transformed the landscape of equine medicine but also contributed significantly to the growth of this vital industry. One of the most significant benefits of technological advancements in equine healthcare is the improvement of diagnostic accuracy. State-of-the-art diagnostic tools, such as digital radiography, magnetic resonance imaging (MRI), and ultrasound, provide veterinarians with clear and precise images of a horse's internal structures. This allows for early detection of health issues, resulting in quicker and more effective treatment, and ultimately reducing the risk of complications. In the digital age, telemedicine has become a game-changer in equine healthcare. Veterinarians can now offer consultations, monitor a horse's condition, and provide guidance remotely, saving time and improving access to expert care. This technology is particularly valuable for horse owners in remote areas or those facing logistical challenges. Technological advancements have also revolutionized equine surgery. Minimally invasive procedures, including arthroscopy and laparoscopy, have reduced the trauma and recovery time associated with traditional surgeries. Horses can return to their normal activities more swiftly, benefiting both their owners and the equine healthcare market. Regenerative medicine is another exciting frontier in equine healthcare. Treatments like stem cell therapy and platelet-rich plasma (PRP) have shown promise in accelerating the healing of injuries and degenerative conditions. These regenerative therapies offer new avenues for treatment and recovery, driving demand within the market.

Expanding Disposable Income

The world of equine healthcare is experiencing a transformation, driven in part by a significant and widespread trend: the expansion of disposable income. As economies prosper and individuals and families enjoy greater financial stability, horse ownership and participation in equestrian activities have become more accessible and affordable. This shift in economic dynamics is not only reshaping the equine landscape but also boosting the growth of the global equine healthcare market. Expanding disposable income has made horse ownership more achievable for a broader demographic. What was once a luxury reserved for a select few is now within reach for many individuals and families. This democratization of horse ownership has resulted in a surge in the number of horses worldwide, increasing the demand for equine healthcare products and services. As disposable income grows, so does the inclination to invest in recreational pursuits. Horses have transitioned from traditional roles in farming and transportation to becoming valued companions and recreational partners. This shift has led to greater expenditure on equine care, including preventive healthcare, nutrition, and veterinary services. With higher income levels, horse owners are more willing to invest in premium products and services for their equine companions. This includes high-quality feed and supplements, top-notch veterinary care, advanced diagnostics, and specialized treatments. As a result, the equine healthcare market has expanded to meet the demand for these premium offerings. Expanding disposable income has led to increased participation in equestrian sports and activities. Individuals and families can now afford riding lessons, horse training, and participation in competitive events. The more horses are involved in these activities, the greater the demand for equine healthcare solutions to ensure their performance and well-being. Higher disposable income has shifted the focus from mere horse ownership to the well-being and longevity of equine companions. Horse owners are more willing to invest in preventive healthcare measures, regular check-ups, dental care, and nutritional plans to ensure their horses lead healthy, fulfilling lives.

Key Market Challenges

High Cost of Specialized Care

One of the foremost challenges in the equine healthcare market is the high cost associated with specialized care. Horses, unlike smaller companion animals, often require specialized veterinary services, medications, and equipment, all of which come at a premium. This can deter some horse owners from seeking proper care, potentially compromising the health of their animals.

Limited Availability of Skilled Veterinarians

Equine veterinarians are a specialized breed themselves, and their numbers can be limited in some regions. Finding qualified and experienced equine veterinarians can be challenging, especially in rural areas. This scarcity can lead to delays in care and potentially inadequate treatment.

Resistance to Change

Despite advancements in equine healthcare, some horse owners and trainers may resist adopting new practices or technologies. Tradition often plays a significant role in horse care, and convincing stakeholders to embrace innovation can be a gradual process.

Cost-Effective Alternatives

While some horse owners are willing to invest significantly in their animals' health, others may seek cost-effective alternatives. This can lead to the use of less proven or non-veterinary approaches to healthcare, potentially putting horses at risk.

Key Market Trends

Telemedicine and Remote Monitoring

Telemedicine is rapidly gaining traction in the equine healthcare industry. Horse owners and veterinarians are increasingly using digital platforms to facilitate remote consultations, monitor vital signs, and manage health records. This trend enhances convenience, reduces travel stress for horses, and allows for prompt assessment and intervention, particularly in remote areas.

Precision Medicine and Personalized Care

The equine healthcare market is moving towards a more personalized approach. Advances in genetics and diagnostics enable tailored treatments and nutrition plans for individual horses. Precision medicine ensures that each horse receives care specifically designed to meet its unique needs, optimizing health and performance.

Regenerative Therapies

Regenerative therapies, such as stem cell treatments and platelet-rich plasma (PRP) therapy, are gaining prominence in the equine healthcare sector. These innovative treatments offer the potential to accelerate healing, manage musculoskeletal issues, and improve overall well-being in horses. As research continues, regenerative therapies are likely to become more accessible and widely adopted.

Wearable Health Monitoring Devices

Wearable technology is making its mark in equine healthcare. Equipped with sensors and trackers, wearable devices monitor vital signs, movement, and behavior in real-time. These devices provide valuable data for veterinarians and horse owners to assess health, track performance, and detect issues early.

Segmental Insights

Product Insights

Based on the category of Product, the pharmaceutical industry held a dominant position in the market in 2022. Various types of pharmaceutical products designed for horses, including pain relievers, anti-infectives, anti-inflammatory drugs, and parasiticides, were widely used to address a range of equine health issues, such as reproductive, metabolic, infectious, and dermatological disorders. The market for both prescription and non-prescription medications experienced significant growth, driven by increased spending on equestrian activities and overall equine healthcare. This growth can be attributed to the efforts made by industry players. For example, Zoetis offered a comprehensive selection of medications, including equine parasiticides like QUEST gel, Equest Pramox, Deosect 5% Spray Solution, and more.

Looking ahead, the "others" category is expected to exhibit the highest growth rate from 2023 to 2030. This category encompasses regenerative treatments for horses, such as stem cell therapy, among others. The growth of this segment is anticipated to be fueled by increased research and development activities in the field of equine medicine. In June 2021, Zoetis introduced a range of devices, including Pro-Stride APS, CenTrate BMA, and Restigen PRP, designed to assist in the treatment of injuries in horses that can lead to lameness. These devices simplify the processing of horses' blood or bone marrow, eliminating the need for incubation or off-site preparation and enabling immediate use after centrifugation.

Indication Insights

In 2022, the dominant focus within the market was on controlling parasites. Parasiticides, which encompass treatments for both external parasites (ectoparasiticides) and internal parasites (endoparasiticides), were available in various forms such as sprays, collars, oral solutions, gels, and spot-on treatments. They could be administered through topical, oral, or intravenous methods and were effective in addressing health issues caused by amoebas, helminths, protozoa, and parasitic fungi.

Looking ahead, the segment related to equine influenza is expected to experience the most rapid growth during the forecast period. This growth can be attributed to the increasing prevalence of infectious diseases in horses. According to the OIE (World Organisation for Animal Health), there were more than 12,000 reported cases of equine influenza worldwide between 2017 and 2021. The demand for equine healthcare is on the rise due to mounting pressure to maintain the health of horses and optimize their performance, especially in the case of race and sports horses. Additionally, there is a growing awareness of the importance of preventive measures against equine diseases.

Regional Insights

In 2022, North America held the largest market share. According to data from the FAO (Food and Agriculture Organization), the United States alone had approximately 10.56 million horses in 2021, and the broader North American region boasted around 10.96 million horses. This substantial share was further bolstered by the presence of numerous horse farms and an extensive annual calendar of horse races. The United States, for instance, boasts approximately 300 racetracks, hosting nearly 33,567 horse races each year. Additionally, the importation of an estimated 18,865 horses into the U.S. in 2021 contributed to the demand for equine healthcare in North America.

Looking ahead, the Asia-Pacific (APAC) region is projected to experience the most rapid growth during the forecast period. This growth can be attributed to several factors, including an increased demand for medicinal horse feeds, a rise in the prevalence of equine diseases, and government initiatives aimed at promoting equine health. Furthermore, the presence of numerous market participants operating in the equine products sector is expected to exert a significant influence on market growth in the coming years.

Key Market Players

Zoetis Inc.

Boehringer Ingelheim GmbH

Merck & Co., Inc.

Hallmarq Veterinary Imaging Ltd

Esaote SpA

Vetoquinol SA

IDEXX Laboratories, Inc.

Dechra Pharmaceuticals PLC

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

Equine Healthcare Market, By Indication:

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

Equine Healthcare Market, By Activity:

  • Sports/Racing
  • Recreation
  • Others

Equine Healthcare Market, By Distribution Channel:

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Equine Healthcare Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

  • Global Equine Healthcare market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Indication
    • 5.3.3. By Activity
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Equine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 6.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 6.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 6.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Activity
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Equine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Activity
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Equine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Activity
        • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 7.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 7.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 7.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Equine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Activity
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. United Kingdom Equine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Activity
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. France Equine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Activity
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Equine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Activity
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Equine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Activity
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 8.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 8.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 8.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Activity
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Japan Equine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Activity
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. India Equine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Activity
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Australia Equine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Activity
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. South Korea Equine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Activity
        • 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 9.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 9.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 9.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Activity
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Equine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Activity
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Equine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Activity
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 10.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 10.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 10.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Activity
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Activity
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Equine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Activity
        • 10.3.3.2.4. By Distribution Channel
    • 10.3.4. Kuwait Equine Healthcare Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Indication
        • 10.3.4.2.3. By Activity
        • 10.3.4.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Zoetis Inc.
    • 14.6.2. Boehringer Ingelheim GmbH
    • 14.6.3. Merck & Co., Inc.
    • 14.6.4. Hallmarq Veterinary Imaging Ltd
    • 14.6.5. Esaote SpA
    • 14.6.6. Vetoquinol SA
    • 14.6.7. IDEXX Laboratories, Inc.
    • 14.6.8. Dechra Pharmaceuticals PLC

15. Strategic Recommendations

16. About Us & Disclaimer